Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murat Akova

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Intensive & Critical Care Nursing|October 15, 2025
Sepsis in the older intensive care unit patient: current insights and nursing prioritiesCemre Boşnak, Murat Akova
Infectious Diseases & Clinical Microbiology|March 11, 2026
Influenza Pandemics After COVID-19: Still a Credible Threat in a Broader Pandemic LandscapeÖnder Ergönül, Murat Akova
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2017
Antibacterial Resistance in Patients with Hematopoietic Stem Cell TransplantationSehnaz Alp, Murat Akova
Current Opinion in Infectious Diseases|September 2, 2016
Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?Gökhan Metan, Murat Akova
Intensive Care Medicine|December 21, 2016
An overview on severe infections in EuropeGeorge Dimopoulos, Murat Akova
Expert Opinion on Pharmacotherapy|May 31, 2006
Treatment of invasive infections due to rare or emerging yeasts and mouldsGulsen Ozkaya Sahin, Murat Akova
Antibiotics (Basel, Switzerland)|February 25, 2022
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor CombinationsAbdullah Tarık Aslan, Murat Akova
Expert Review of Anti-Infective Therapy|November 14, 2019
Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing optionsAbdullah Tarık Aslan, Murat Akova
The Lancet. Infectious Diseases|September 16, 2022
Time to redefine a primary vaccination series?Mine Durusu Tanriover, Murat Akova
Le Infezioni in Medicina|February 11, 2022
Current status of therapeutic alternatives for COVID-19: A narrative reviewAbdullah Tarık Aslan, Murat Akova
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Intensive & Critical Care Nursing|October 15, 2025
Sepsis in the older intensive care unit patient: current insights and nursing prioritiesCemre Boşnak, Murat Akova
Infectious Diseases & Clinical Microbiology|March 11, 2026
Influenza Pandemics After COVID-19: Still a Credible Threat in a Broader Pandemic LandscapeÖnder Ergönül, Murat Akova
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2017
Antibacterial Resistance in Patients with Hematopoietic Stem Cell TransplantationSehnaz Alp, Murat Akova
Current Opinion in Infectious Diseases|September 2, 2016
Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?Gökhan Metan, Murat Akova
Intensive Care Medicine|December 21, 2016
An overview on severe infections in EuropeGeorge Dimopoulos, Murat Akova
Expert Opinion on Pharmacotherapy|May 31, 2006
Treatment of invasive infections due to rare or emerging yeasts and mouldsGulsen Ozkaya Sahin, Murat Akova
Antibiotics (Basel, Switzerland)|February 25, 2022
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor CombinationsAbdullah Tarık Aslan, Murat Akova
Expert Review of Anti-Infective Therapy|November 14, 2019
Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing optionsAbdullah Tarık Aslan, Murat Akova
The Lancet. Infectious Diseases|September 16, 2022
Time to redefine a primary vaccination series?Mine Durusu Tanriover, Murat Akova
Le Infezioni in Medicina|February 11, 2022
Current status of therapeutic alternatives for COVID-19: A narrative reviewAbdullah Tarık Aslan, Murat Akova
Pageof 18